The landscape of dementia analysis has advanced radically with the appearance of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that may detect Alzheimer's pathology many years before indications arise. Even though these technological developments represent extraordinary development in knowing neurodegenerative diseases, they may have not https://emilyb096ebl3.wikimidpoint.com/user